Company Filing History:
Years Active: 2013
Title: Thomas Binz: Innovator in Neurotoxin Research
Introduction
Thomas Binz is a prominent inventor based in Hannover, Germany. He is known for his significant contributions to the field of neurotoxin research. His work has led to advancements in understanding the mechanisms of botulinum neurotoxin A.
Latest Patents
Thomas Binz holds a patent for a groundbreaking invention titled "Botulinum neurotoxin A protein receptor and uses thereof." This invention relates to an isolated polypeptide of the luminal domain of synaptic vesicle glycoprotein 2C, wherein at least 70 percent of the amino acid sequence is identical to the amino acid sequence of the SV2C. The polypeptide binds the H fragment of botulinum neurotoxin A, provided that the polypeptide is not the synaptic vesicle glycoprotein 2C.
Career Highlights
Throughout his career, Thomas Binz has made significant strides in the field of biotechnology. He is currently associated with Toxogen GmbH, where he continues to innovate and develop new solutions in neurotoxin research. His work has garnered attention for its potential applications in various medical fields.
Collaborations
Thomas Binz has collaborated with notable colleagues, including Stefan Mahrhold and Johannes Wilhelm Bigalke. These partnerships have further enhanced his research and contributed to the advancement of neurotoxin studies.
Conclusion
In summary, Thomas Binz is a key figure in neurotoxin research, with a patent that showcases his innovative approach to understanding botulinum neurotoxin A. His contributions continue to impact the field significantly.